MedTrace Logo

Intravenous Paracetamol in Combination With Caudal Ropivacaine

NCT03781505 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-08-16

Study results available
· View outcomes & findings →

Summary

To investigate whether the addition of intravenous paracetamol with caudal ropivacaine leads to better quality of postoperative recovery in patients undergoing hypospadius repair than caudal ropivacaine alone. The quality of recovery will be judged by postoperative analgesia requirement and lesser agitation in the postoperative period.

Conditions

  • Postoperative Analgesia

Interventions

DRUG

Paracetamol +caudal ropivacaine

Paracetamol + Ropivacaine

DRUG

Placebo

Caudal ropivacaine

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Muhammad S Yousuf, FCPS · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2022-04-30
Completion
2022-05-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03781505 on ClinicalTrials.gov